Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

November 24, 2020

Study Completion Date

May 27, 2021

Conditions
Actinic Keratosis
Interventions
DRUG

Photodynamic therapy (PDT)

"PDT is a technique that combines a photosensitizing drug and an intense light source to kill tumor cells~Noninvasive fluorescence dosimetry may be performed on up to 6 lesions. Levulan Kerastick will be applied to each lesion and left to incubate for 30 minutes. Blue light (Blu-U device, 20 J/cm2, 33 minutes) will be administered."

DRUG

Vitamin D3

"D3 pills (10,000 IU each) to be taken daily at home, beginning at either day -5 or day -14, as per their assignment~Participants will receive a 5-day or 14-day supplementation of Vitamin D10,000 IU depending on their baseline Vitamin D 25 Hydroxy result"

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT04140292 - Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses | Biotech Hunter | Biotech Hunter